Press Releases

Press Release

Back
Anthem Provides Nationwide Coordinated Response to COVID-19

INDIANAPOLIS--(BUSINESS WIRE)--Apr. 29, 2020-- Against the backdrop of the national healthcare crisis, Anthem, Inc. (NYSE: ANTM) has been deeply committed to supporting its health plan members, customers, care providers, associates and local communities through affordable care and lasting recovery.

“Anthem recognizes the important role we play as part of the national response to the COVID-19 pandemic,” said President and CEO Gail K. Boudreaux. “Guided by our mission and values, Anthem is engaging across the country and in our local communities to support our members, customers and partners with relief and care during this challenging time. We are grateful to all those fighting on the front lines of this healthcare crisis, and will continue to stand with them as we work through this pandemic together.”

Anthem’s deep roots in the community combined with its legacy and commitment to leadership, innovation and agility, have enabled the company to quickly and seamlessly work with local, state and federal officials, care providers, customers and community partners in the face of the pandemic.

As part of Anthem’s coordinated response, the company has been focused on increasing access and coverage, adapting tools and policies, leveraging its expertise in data and advanced analytics to provide innovative solutions, and delivering outreach and relief to those in need. Details regarding the company’s actions include the following:

Care for our Anthem associates

  • Deployed business continuity plans and transitioned nearly all of our associates to work from home while maintaining service operations.
  • Expanded associate benefits to provide additional support, including providing up to 80 hours of paid leave, reimbursement of installation and monthly internet service fees for hourly associates, and offering virtual wellbeing resources.
  • Ensuring our frontline medical staff are following CDC guidelines and are equipped with the proper equipment and supplies to minimize risk to themselves and patients.

Care for our consumers, customers, and providers

  • Waived all cost-sharing for COVID diagnostic tests as well as treatment.
  • Increased access to virtual care and waived cost-sharing for telehealth and phone visits, including those for mental health.
  • Relaxed early prescription refill policies for maintenance and specialty medications - proactively encouraging the use of home delivery services ensuring continuous access to necessary medications.
  • Developed a Coronavirus Assessment tool within our Sydney Care app to help people quickly and safely evaluate symptoms, assess their risk of having COVID-19, and connect directly to a board-certified doctor via text or video. Doctors can recommend treatment options, and if needed, members can locate the nearest testing site using our site locator tool within the Sydney Care app.
  • Suspended select prior authorization requirements.
  • Recruiting and expediting the onboarding of care providers interested in providing telehealth services to members via Anthem's telehealth service, Live Health Online.
  • Providing post-discharge support to Medicare members with complex care needs who may need additional assistance as they transition back home following hospitalization.
  • Providing no-cost access to Employee Assistance Program (EAP) informational resources for 90 days to those members who do not already have access.
  • Providing resources to support the whole health needs of members, including resources to manage social isolation, job loss, food insecurity and stress.
  • Offering enhanced flexibility with regard to premium payments to eligible employer groups.

 

 

Care for our communities

  • Committed $50 million from the Anthem Foundation for COVID-19 response and recovery efforts to help areas of greatest need, including care provider safety, food insecurity, and mental and behavioral health resources.
  • The Anthem Foundation is matching 200 percent of associate donations to certain charities.
  • Launched the Anthem Medical Associate Volunteer Program, allowing associates with professional medical training to take paid leave and volunteer to serve on the frontline in communities in need.
  • Partnering with NYC-based Coalition of Asian-American IPA, an independent practice association with over 1,000 private practice providers, to provide free mobile testing across NYC while increasing access to testing in many other markets across the U.S.
  • CEO contributed two month's salary to Anthem Foundation to support associate emergency relief fund, food banks, and protective equipment for healthcare workers in Indiana.
  • Partnered with ConvenientMD to provide drive-up testing services in Maine and New Hampshire.
  • With our Association of 35 other independent Blue Cross and Blue Shield companies, we have committed nearly $3 billion to ensure that more than 100 million Americans, along with care providers and hospitals, have access to necessary resources and support.
  • Providing virtual volunteer opportunities, like remote teaching or mailing cards to seniors faced with loneliness, to help associates safely give back to their communities.
  • Provided 20,000 hospital gowns Trinitas Regional Health Center in New Jersey.
  • Contributing $1 million to the newly created Rapid Response Loan Fund established by the Indianapolis Chamber of Commerce to provide critical funding for the nearly 43 thousand small businesses in Central Indiana.
  • Partnering with X Prize and other industry leaders to form a Global Pandemic Alliance to combat COVID-19 as well as prepare for future pandemics.
  • Engaging with our key industry partners, such as Blue Cross Blue Shield Association and America's Health Insurance Plans, as well as state and federal lawmakers and regulators to help shape and guide policy decisions to support our members, customers, and care providers.
  • Serving on the Great American Economic Revival Industry Groupled by President Trump designed to bring together business leaders from various industries and geographies to discuss the pragmatic and thoughtful path forward to re-starting the economy.

 

CONSOLIDATED HIGHLIGHTS

Earnings Per Share: GAAP net income was $5.94 per share in the quarter, including net negative adjustment items of $0.54 per share. Adjusted net income was $6.48* per share.

*Please refer to the GAAP reconciliation tables.

Membership: Medical enrollment totaled 42.1 million members at March 31, 2020, an increase of 1.3 million, or 3.2 percent, from March 31, 2019. Risk enrollment grew by 676 thousand lives, or 4.4 percent, and fee-based enrollment grew by 625 thousand lives, or 2.5 percent. Government Business enrollment increased by 849 thousand lives over the prior year quarter, driven by Medicaid, reflecting the acquisition of Medicaid members in Missouri and Nebraska and organic growth in our markets, and Medicare Advantage. Commercial & Specialty Business enrollment grew by 452 thousand lives driven by growth in the fee-based businesses, including the acquisition of AmeriBen, a third-party administrator (TPA).

During the first quarter of 2020, medical enrollment increased sequentially by 1.1 million lives, or 2.8 percent, reflecting growth in the National and Medicaid businesses, in part due to the aforementioned acquisitions.

Operating Revenue: Operating revenue was $29.4 billion in the first quarter of 2020, an increase of $5.1 billion, or 20.7 percent, versus the prior year quarter, driven by pharmacy product revenue related to the launch of IngenioRx. The increase was further attributable to higher premium revenue from rate increases to cover overall cost trends, including the return of the health insurance tax in 2020, and membership growth.

Benefit Expense Ratio: The benefit expense ratio was 84.2 percent in the first quarter of 2020, a decrease of 20 basis points from 84.4 percent in the prior year quarter. The decrease, as expected, was primarily driven by the return of the health insurance tax in 2020, partially offset by the extra calendar day in the first quarter of 2020 and margin normalization in the Individual business.

Medical claims reserves established at December 31, 2019 developed in line with the Company’s expectations during the first quarter of 2020.

Days in Claims Payable: Days in Claims Payable was 41.9 days as of March 31, 2020, an increase of 3.9 days from December 31, 2019.

SG&A Expense Ratio: The SG&A expense ratio was 12.8 percent in the first quarter of 2020, a decrease of 20 basis points from 13.0 percent in the first quarter of 2019, primarily driven by growth in operating revenue. The decrease was partially offset by the return of the health insurance tax in 2020 and increased spend to support growth initiatives.

Operating Cash Flow: Operating cash flow was $2.5 billion, or 1.7 times net income in the first quarter of 2020, an increase of $885 million compared to the prior year quarter, primarily driven by growth in premium revenue due to the return of the health insurance tax in 2020 and changes in working capital.

Share Repurchase Program: During the first quarter of 2020, the Company repurchased 1.9 million shares of its common stock for $529 million, or a weighted average price of $275.38. In response to circumstances arising from the COVID-19 pandemic, the Company has temporarily suspended share repurchase activity to enhance liquidity and financial flexibility. As of March 31, 2020, the Company had approximately $3.3 billion of Board-approved share repurchase authorization remaining.

Cash Dividend: During the first quarter of 2020, the Company paid a quarterly dividend of $0.95 per share, representing a distribution of cash totaling $240 million.

On April 28, 2020, the Audit Committee declared a second quarter 2020 dividend to shareholders of $0.95 per share. On an annualized basis, this equates to a dividend of $3.80 per share. The second quarter dividend is payable on June 25, 2020 to shareholders of record at the close of business on June 10, 2020.

Investment Portfolio & Capital Position: During the first quarter of 2020, the Company recorded net realized losses of $24 million and impairment losses totaling $57 million. During the first quarter of 2019, the Company recorded net realized gains of $78 million and impairment losses totaling $10 million.

As of March 31, 2020, the Company’s net unrealized loss position in the investment portfolio was $263 million, consisting of fixed maturity securities. As of March 31, 2020 cash and investments at the parent company totaled approximately $1.7 billion.

REPORTABLE SEGMENTS

Effective January 1, 2020, Anthem, Inc. has four reportable segments: Commercial & Specialty Business (comprised of the Local Group, National Accounts, Individual and Specialty businesses); Government Business (comprised of the Medicaid, Medicare, and Federal Health Products & Services businesses); IngenioRx, and Other (comprised of the Diversified Business Group and corporate expenses not allocated to our other reportable segments).

 

 

 

 

 

 

 

 

 

 

 

Anthem, Inc.

 

 

Reportable Segment Highlights

 

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

(In millions)

 

Three Months Ended March 31

 

 

 

 

2020

 

2019

 

Change

 

 

Operating Revenue

 

 

 

 

 

 

 

 

 

Commercial & Specialty Business

 

$9,361

 

$9,392

 

(0.3

)%

 

 

Government Business

 

17,466

 

14,925

 

17.0

%

 

 

IngenioRx

 

5,197

 

 

NM2

 

 

Other

 

1,027

 

548

 

87.4

%

 

 

Eliminations

 

(3,603)

 

(477)

 

NM2

 

 

Total Operating Revenue1

 

$29,448

 

$24,388

 

20.7

%

 

 

 

 

 

 

 

 

 

 

 

 

Operating Gain / (Loss)

 

 

 

 

 

 

 

 

 

Commercial & Specialty Business

 

$1,420

 

$1,598

 

(11.1

)%

 

 

Government Business

 

411

 

374

 

9.9

%

 

 

IngenioRx

 

349

 

 

NM2

 

 

Other

 

14

 

(32)

 

NM2

 

 

Total Operating Gain1

 

$2,194

 

$1,940

 

13.1

%

 

 

 

 

 

 

 

 

 

 

 

 

Operating Margin

 

 

 

 

 

 

 

 

 

Commercial & Specialty Business

 

15.2

%

 

17.0

%

 

(180) bp

 

 

 

Government Business

 

2.4

%

 

2.5

%

 

(10) bp

 

 

 

IngenioRx

 

6.7

%

 

 

 

NM2

 

 

Total Operating Margin1

 

7.5

%

 

8.0

%

 

(50) bp

 

 

 

 

 

 

 

 

 

 

 

 

(1) See “Basis of Presentation.”

(2)"NM" = calculation not meaningful.

Commercial & Specialty Business: Operating gain in the Commercial & Specialty Business segment totaled $1,420 million in the first quarter of 2020, a decrease of $178 million, or 11.1 percent, from $1,598 million in the first quarter of 2019. The decrease is primarily attributable to margin normalization in the Individual business and the shift of pharmacy earnings to the IngenioRx segment. The decrease is further due to the impact of one extra calendar day compared to the prior year quarter, partially offset by growth in value-added services.

Government Business: Operating gain in the Government Business segment was $411 million in the first quarter of 2020, an increase of $37 million, or 9.9 percent, from $374 million in the first quarter of 2019. The increase is primarily due to higher premiums from rate adjustments and membership growth in the Medicaid business as well as the return of the health insurance tax in 2020, partially offset by higher selling, general, and administrative spend to support growth as well as the impact of one extra calendar day compared to the prior year quarter.

IngenioRx: IngenioRx commenced operations in the second quarter of 2019. Operating gain was $349 million in the first quarter of 2020.

Other: The Company reported an operating gain of $14 million in the Other segment for the first quarter of 2020, compared with an operating loss of $32 million in the prior year quarter.

OUTLOOK

Full Year 2020:

  • GAAP net income is expected to be greater than $21.00 per share, including approximately $1.30 per share of net unfavorable items. Excluding these items, adjusted net income is expected to be greater than $22.30* per share.

Due to unprecedented uncertainty around the COVID-19 pandemic and its impact, the Company is withdrawing all other previously issued financial guidance metrics for 2020 until visibility improves.

* Refer to the GAAP reconciliation tables.

Basis of Presentation

  1. Operating revenue and operating gain are the key measures used by management to evaluate performance in each of its reporting segments, allocate resources, set incentive compensation targets and to forecast future operating performance. Operating gain is calculated as total operating revenue less benefit expense, cost of products sold and selling, general and administrative expense. It does not include net investment income, net realized gains/losses on financial instruments, other-than-temporary impairment losses recognized in income, interest expense, amortization of other intangible assets, gains/losses on extinguishment of debt or income taxes, as these items are managed in a corporate shared service environment and are not the responsibility of operating segment management. Refer to the GAAP reconciliation tables.
  2. Operating margin is defined as operating gain divided by operating revenue.

Conference Call and Webcast

Management will host a conference call and webcast today at 8:30 a.m. Eastern Daylight Time (“EDT”) to discuss the company’s first quarter results and outlook. The conference call should be accessed at least 15 minutes prior to the start of the call with the following numbers:

877-692-8955 (Domestic)

 

866-207-1041 (Domestic Replay)

234-720-6979 (International)

 

402-970-0847 (International Replay)

The access code for today's conference call is 1722374. The access code for the replay is 3836663. The replay will be available from 11:30 a.m. EDT today, until the end of the day on May 13, 2020. The call will also be available through a live webcast at www.antheminc.com under the “Investors” link. A webcast replay will be available following the call.

About Anthem, Inc.

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 108 million people, including more than 42 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.

Anthem, Inc.

Membership Summary

(Unaudited and in Thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change from

Medical Membership

 

March 31,
2020

 

March 31,
2019

 

December 31,
2019

 

March 31,
2019

 

December 31,
2019

Customer Type

 

 

 

 

 

 

 

 

 

 

Local Group

 

15,848

 

 

15,697

 

 

15,682

 

 

1.0

%

 

1.1

%

Individual

 

717

 

 

773

 

 

684

 

 

(7.2

)%

 

4.8

%

 

 

 

 

 

 

 

 

 

 

 

National:

 

 

 

 

 

 

 

 

 

 

National Accounts

 

7,898

 

 

7,757

 

 

7,596

 

 

1.8

%

 

4.0

%

BlueCard®

 

6,197

 

 

5,981

 

 

6,060

 

 

3.6

%

 

2.3

%

Total National

 

14,095

 

 

13,738

 

 

13,656

 

 

2.6

%

 

3.2

%

 

 

 

 

 

 

 

 

 

 

 

Medicare:

 

 

 

 

 

 

 

 

 

 

Medicare Advantage

 

1,341

 

 

1,144

 

 

1,214

 

 

17.2

%

 

10.5

%

Medicare Supplement

 

914

 

 

867

 

 

905

 

 

5.4

%

 

1.0

%

Total Medicare

 

2,255

 

 

2,011

 

 

2,119

 

 

12.1

%

 

6.4

%

 

 

 

 

 

 

 

 

 

 

 

Medicaid

 

7,615

 

 

7,033

 

 

7,265

 

 

8.3

%

 

4.8

%

Federal Employees Health Benefits

 

1,614

 

 

1,591

 

 

1,594

 

 

1.4

%

 

1.3

%

Total Medical Membership

 

42,144

 

 

40,843

 

 

41,000

 

 

3.2

%

 

2.8

%

                               

Funding Arrangement

 

 

 

 

 

 

 

 

 

 

Self-Funded

 

26,120

 

 

25,495

 

 

25,418

 

 

2.5

%

 

2.8

%

Fully-Insured

 

16,024

 

 

15,348

 

 

15,582

 

 

4.4

%

 

2.8

%

Total Medical Membership

 

42,144

 

 

40,843

 

 

41,000

 

 

3.2

%

 

2.8

%

Reportable Segment

 

 

 

 

 

 

 

 

 

 

Commercial & Specialty Business

 

30,660

 

 

30,208

 

 

30,022

 

 

1.5

%

 

2.1

%

Government Business

 

11,484

 

 

10,635

 

 

10,978

 

 

8.0

%

 

4.6

%

Total Medical Membership

 

42,144

 

 

40,843

 

 

41,000

 

 

3.2

%

 

2.8

%

Other Membership

 

 

 

 

 

 

 

 

 

 

Life and Disability Members

 

5,158

 

 

4,849

 

 

5,259

 

 

6.4

%

 

(1.9

)%

Dental Members

 

6,172

 

 

5,955

 

 

5,962

 

 

3.6

%

 

3.5

%

Dental Administration Members

 

1,311

 

 

5,491

 

 

5,516

 

 

(76.1

)%

 

(76.2

)%

Vision Members

 

7,510

 

 

7,169

 

 

7,261

 

 

4.8

%

 

3.4

%

Medicare Part D Standalone Members

 

383

 

 

289

 

 

283

 

 

32.5

%

 

35.3

%

Anthem, Inc.

Consolidated Statements of Income

(Unaudited)

 

 

 

 

 

 

 

 

(In millions, except per share data)

 

Three Months Ended
March 31

 

 

 

 

 

2020

 

2019

 

Change

Revenues

 

 

 

 

 

 

 

Premiums

 

$

25,517

 

 

$

22,843

 

 

11.7

%

Product revenue

 

2,344

 

 

 

 

NM

 

Administrative fees and other revenue

 

1,587

 

 

1,545

 

 

2.7

%

Total operating revenue

 

29,448

 

 

24,388

 

 

20.7

%

Net investment income

 

254

 

 

210

 

 

21.0

%

Net realized (losses)/gains on financial instruments

 

(24

)

 

78

 

 

NM

 

Impairment losses on investments:

 

 

 

 

 

 

 

Total impairment losses on investments

 

(101

)

 

(13

)

 

NM

 

Portion of impairment losses recognized in other comprehensive income

 

44

 

 

3

 

 

NM

 

Impairment losses recognized in income

 

(57

)

 

(10

)

 

NM

 

 

 

 

 

 

 

 

 

Total revenues

 

29,621

 

 

24,666

 

 

20.1

%

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

Benefit expense

 

21,489

 

 

19,282

 

 

11.4

%

Cost of products sold

 

1,984

 

 

 

 

NM

 

Selling, general and administrative expense

 

3,781

 

 

3,166

 

 

19.4

%

Interest expense

 

194

 

 

187

 

 

3.7

%

Amortization of other intangible assets

 

83

 

 

87

 

 

(4.6

)%

Loss/(gain) on extinguishment of debt

 

1

 

 

(1

)

 

NM

 

 

 

 

 

 

 

 

 

Total expenses

 

27,532

 

 

22,721

 

 

21.2

%

 

 

 

 

 

 

 

 

Income before income tax expense

 

2,089

 

 

1,945

 

 

7.4

%

 

 

 

 

 

 

 

 

Income tax expense

 

566

 

 

394

 

 

43.7

%

 

 

 

 

 

 

 

 

Net income

 

$

1,523

 

 

$

1,551

 

 

(1.8

)%

 

 

 

 

 

 

 

 

Net income per diluted share

 

$

5.94

 

 

$

5.91

 

 

0.5

%

 

 

 

 

 

 

 

 

Diluted shares

 

256.4

 

 

262.3

 

 

(2.2

)%

 

 

 

 

 

 

 

 

Benefit expense as a percentage of premiums

 

84.2

%

 

84.4

%

 

(20

)bp

Selling, general and administrative expense as a percentage of total operating revenue

 

12.8

%

 

13.0

%

 

(20

)bp

Income before income taxes as a percentage of total revenue

 

7.1

%

 

7.9

%

 

(80

)bp

"NM" = calculation not meaningful

 

Anthem, Inc.

Consolidated Balance Sheets

 

(In millions)

 

March 31,
2020

 

December 31,
2019

Assets

 

(Unaudited)

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

5,345

 

 

$

4,937

 

Fixed maturity securities, current

 

19,881

 

 

19,676

 

Equity securities, current

 

570

 

 

1,009

 

Premium receivables

 

5,786

 

 

5,014

 

Self-funded receivables

 

2,613

 

 

2,570

 

Other receivables

 

2,926

 

 

2,807

 

Other current assets

 

4,135

 

 

3,020

 

Total current assets

 

41,256

 

 

39,033

 

 

 

 

 

 

Long-term investments:

 

 

 

 

Fixed maturity securities

 

505

 

 

505

 

Other invested assets

 

4,181

 

 

4,258

 

Property and equipment, net

 

3,350

 

 

3,133

 

Goodwill

 

21,661

 

 

20,500

 

Other intangible assets

 

9,613

 

 

8,674

 

Other noncurrent assets

 

1,833

 

 

1,350

 

Total assets

 

$

82,399

 

 

$

77,453

 

 

 

 

 

 

Liabilities and shareholders’ equity

 

 

 

 

Liabilities

 

 

 

 

Current liabilities:

 

 

 

 

Medical claims payable

 

$

9,902

 

 

$

8,842

 

Other policyholder liabilities

 

3,252

 

 

3,050

 

Unearned income

 

947

 

 

1,017

 

Accounts payable and accrued expenses

 

5,058

 

 

4,198

 

Short-term borrowings

 

1,075

 

 

700

 

Current portion of long-term debt

 

1,603

 

 

1,598

 

Other current liabilities

 

5,202

 

 

4,127

 

Total current liabilities

 

27,039

 

 

23,532

 

 

 

 

 

 

Long-term debt, less current portion

 

19,005

 

 

17,787

 

Reserves for future policy benefits

 

754

 

 

759

 

Deferred tax liabilities, net

 

2,213

 

 

2,227

 

Other noncurrent liabilities

 

1,695

 

 

1,420

 

Total liabilities

 

50,706

 

 

45,725

 

 

 

 

 

 

Shareholders’ equity

 

 

 

 

Common stock

 

3

 

 

3

 

Additional paid-in capital

 

9,338

 

 

9,448

 

Retained earnings

 

23,360

 

 

22,573

 

Accumulated other comprehensive loss

 

(1,008

)

 

(296

)

Total shareholders’ equity

 

31,693

 

 

31,728

 

Total liabilities and shareholders’ equity

 

$

82,399

 

 

$

77,453

 

Anthem, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

 

 

 

(In millions)

 

Three Months Ended March 31

 

 

2020

 

2019

Operating activities

 

 

 

 

 

Net income

 

$

1,523

 

 

$

1,551

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Net realized losses (gains) on financial instruments

 

 

24

 

 

 

(78

)

Depreciation and amortization

 

 

270

 

 

 

289

 

Deferred income taxes

 

 

57

 

 

 

55

 

Share-based compensation

 

 

67

 

 

 

70

 

Changes in operating assets and liabilities:

 

 

 

 

 

Receivables, net

 

 

(639

)

 

 

(753

)

Other invested assets

 

 

63

 

 

 

(21

)

Other assets

 

 

(525

)

 

 

(125

)

Policy liabilities

 

 

692

 

 

 

791

 

Unearned income

 

 

(109

)

 

 

96

 

Accounts payable and other liabilities

 

 

588

 

 

 

(354

)

Income taxes

 

 

491

 

 

 

115

 

Other, net

 

 

13

 

 

 

(6

)

Net cash provided by operating activities

 

 

2,515

 

 

 

1,630

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

Purchases of investments

 

 

(3,896

)

 

 

(6,069

)

Proceeds from sale of investments

 

 

2,728

 

 

 

5,236

 

Maturities, calls and redemptions from investments

 

 

597

 

 

 

393

 

Purchases of subsidiaries, net of cash acquired

 

 

(1,908

)

 

 

Purchases of property and equipment

 

 

(204

)

 

 

(234

)

Other, net

 

 

(101

)

 

 

22

 

Net cash used in investing activities

 

 

(2,784

)

 

 

(652

)

 

 

 

 

 

 

Financing activities

 

 

 

 

 

Net proceeds from commercial paper borrowings

 

 

905

 

 

 

178

 

Net proceeds from (repayments of) short-term borrowings

 

 

375

 

 

 

(50

)

Net proceeds from (repayments of) long-term borrowings

 

 

248

 

 

 

(61

)

Repurchase and retirement of common stock

 

 

(529

)

 

 

(294

)

Cash dividends

 

 

(240

)

 

 

(206

)

Proceeds from issuance of common stock under employee stock plans

 

 

44

 

 

 

76

 

Taxes paid through withholding of common stock under employee stock plans

 

 

(107

)

 

 

(78

)

Other, net

 

 

(17

)

 

 

6

 

Net cash provided by (used in) financing activities

 

 

679

 

 

 

(429

)

 

 

 

 

 

 

Effect of foreign exchange rates on cash and cash equivalents

 

 

(2

)

 

 

(1

)

 

 

 

 

 

 

Change in cash and cash equivalents

 

 

408

 

 

 

548

 

Cash and cash equivalents at beginning of year

 

 

4,937

 

 

 

3,934

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

5,345

 

 

$

4,482

 

Anthem, Inc.

Reconciliation of Medical Claims Payable

 

 

 

Three Months Ended
March 31

 

Years Ended December 31

 

 

2020

 

2019

 

2019

 

2018

 

2017

(In millions)

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross medical claims payable, beginning of period

 

$

8,647

 

 

$

7,266

 

 

$

7,266

 

 

$

7,814

 

 

$

7,656

 

Ceded medical claims payable, beginning of period

 

(33

)

 

(34

)

 

(34

)

 

(105

)

 

(539

)

Net medical claims payable, beginning of period

 

8,614

 

 

7,232

 

 

7,232

 

 

7,709

 

 

7,117

 

 

 

 

 

 

 

 

 

 

 

 

Business combinations and purchase adjustments

 

339

 

 

 

 

 

 

199

 

 

76

 

 

 

 

 

 

 

 

 

 

 

 

Net incurred medical claims:

 

 

 

 

 

 

 

 

 

 

Current year

 

21,230

 

 

18,794

 

 

78,695

 

 

69,581

 

 

70,377

 

Prior years redundancies(1)

 

(700

)

 

(455

)

 

(500

)

 

(930

)

 

(1,133

)

Total net incurred medical claims

 

20,530

 

 

18,339

 

 

78,195

 

 

68,651

 

 

69,244

 

 

 

 

 

 

 

 

 

 

 

 

Net payments attributable to:

 

 

 

 

 

 

 

 

 

 

Current year medical claims

 

13,744

 

 

12,163

 

 

70,294

 

 

62,748

 

 

62,923

 

Prior years medical claims

 

6,109

 

 

5,414

 

 

6,519

 

 

6,579

 

 

5,805

 

Total net payments

 

19,853

 

 

17,577

 

 

76,813

 

 

69,327

 

 

68,728

 

 

 

 

 

 

 

 

 

 

 

 

Net medical claims payable, end of period

 

9,630

 

 

7,994

 

 

8,614

 

 

7,232

 

 

7,709

 

Ceded medical claims payable, end of period

 

60

 

 

34

 

 

33

 

 

34

 

 

105

 

Gross medical claims payable, end of period

 

$

9,690

 

 

$

8,028

 

 

$

8,647

 

 

$

7,266

 

 

$

7,814

 

 

 

 

 

 

 

 

 

 

 

 

Current year medical claims paid as a percentage of current year net incurred medical claims

 

64.7

%

 

64.7

%

 

89.3

%

 

90.2

%

 

89.4

%

 

 

 

 

 

 

 

 

 

 

 

Prior year redundancies in the current year as a percentage of prior year net medical claims payable less prior year redundancies in the current year

 

8.8

%

 

6.7

%

 

7.4

%

 

13.7

%

 

18.9

%

 

 

 

 

 

 

 

 

 

 

 

Prior year redundancies in the current year as a percentage of prior year net incurred medical claims

 

0.9

%

 

0.7

%

 

0.7

%

 

1.3

%

 

1.8

%

 

 

 

 

 

 

 

 

 

 

 

(1) Negative amounts reported for net incurred medical claims related to prior years result from claims being settled for amounts less than originally estimated.

Anthem, Inc.

GAAP Reconciliation

(Unaudited)

Anthem, Inc. has referenced “Adjusted Net Income” and “Adjusted Net Income Per Share,” which are non-GAAP measures, in this document. These non-GAAP measures are not intended to be alternatives to any measure calculated in accordance with GAAP. In addition to these non-GAAP measures, references are made to the measures “Operating Revenue” and “Operating Gain.” Each of these measures is provided to further aid investors in understanding and analyzing the company’s core operating results and comparing Anthem, Inc.’s financial results. A reconciliation of Operating Revenue to Total Revenue is set forth in the Consolidated Statements of Income herein. A reconciliation of the non-GAAP measures to the most directly comparable measures calculated in accordance with GAAP, together with a reconciliation of reportable segments operating gain to income before income tax expense, is reported below.

 

 

Three Months Ended
March 31

 

 

(In millions, except per share data)

 

2020

 

2019

 

Change

Net income

 

$

1,523

 

 

$

1,551

 

 

(1.8

)%

Add / (Subtract):

 

 

 

 

 

 

Net realized losses (gains) on financial instruments

 

24

 

 

(78

)

 

 

Amortization of other intangible assets

 

83

 

 

87

 

 

 

Impairment losses recognized in income

 

57

 

 

10

 

 

 

Loss (gain) on extinguishment of debt

 

1

 

 

(1

)

 

 

Transaction and integration related costs

 

12

 

 

 

 

 

Litigation expenses

 

8

 

 

26

 

 

 

Tax impact of non-GAAP adjustments

 

(46

)

 

(14

)

 

 

Net adjustment items

 

139

 

 

30

 

 

 

Adjusted net income

 

$

1,662

 

 

$

1,581

 

 

5.1

%

 

 

 

 

 

 

 

Net income per diluted share

 

$

5.94

 

 

$

5.91

 

 

0.5

%

Add / (Subtract):

 

 

 

 

 

 

Net realized losses (gains) on financial instruments

 

0.09

 

 

(0.30

)

 

 

Amortization of other intangible assets

 

0.32

 

 

0.33

 

 

 

Impairment losses recognized in income

 

0.22

 

 

0.04

 

 

 

Loss (gain) on extinguishment of debt

 

 

 

 

 

 

Transaction and integration related costs

 

0.05

 

 

 

 

 

Litigation expenses

 

0.03

 

 

0.10

 

 

 

Tax impact of non-GAAP adjustments

 

(0.18

)

 

(0.05

)

 

 

Rounding impact

 

0.01

 

 

 

 

 

Net adjustment items

 

0.54

 

 

0.12

 

 

 

Adjusted net income per diluted share

 

$

6.48

 

 

$

6.03

 

 

7.5

%

 

 

 

 

 

 

 

 

 

Full Year 2020 Outlook

 

 

Net income per diluted share

 

Greater than $21.00

 

 

Add / (Subtract):

 

 

 

 

Net realized losses (gains) on financial instruments

 

0.09

 

 

Impairment losses recognized in income

 

0.22

 

 

Transaction and integration related costs

 

0.05

 

 

Litigation expenses

 

0.03

 

 

Amortization of other intangible assets

 

Approximately $1.32

 

 

Tax impact of non-GAAP adjustments

 

Approximately ($0.41)

 

 

Net adjustment items

 

Approximately $1.30

 

 

Adjusted net income per diluted share

 

Greater than $22.30

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
March 31

 

 

(In millions)

 

2020

 

2019

 

Change

Reportable segments operating gain

 

$

2,194

 

 

$

1,940

 

 

13.1

%

Net investment income

 

254

 

 

210

 

 

 

Net realized (losses)/gains on financial instruments

 

(24

)

 

78

 

 

 

Impairment losses recognized in income

 

(57

)

 

(10

)

 

 

Interest expense

 

(194

)

 

(187

)

 

 

Amortization of other intangible assets

 

(83

)

 

(87

)

 

 

(Loss)/gain on extinguishment of debt

 

(1

)

 

1

 

 

 

Income before income tax expense

 

$

2,089

 

 

$

1,945

 

 

7.4

%

Forward-Looking Statements

This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward- looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent otherwise required by federal securities laws, we do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof. These risks and uncertainties include, but are not limited to: the impact of large scale medical emergencies, such as public health epidemics and pandemics, including COVID-19, and catastrophes; trends in healthcare costs and utilization rates; our ability to secure sufficient premium rates, including regulatory approval for and implementation of such rates; the impact of federal and state regulation, including ongoing changes in the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, as amended, or collectively, the ACA, and the ultimate outcome of legal challenges to the ACA; changes in economic and market conditions, as well as regulations that may negatively affect our liquidity and investment portfolios; our ability to contract with providers on cost-effective and competitive terms; competitive pressures and our ability to adapt to changes in the industry and develop and implement strategic growth opportunities; reduced enrollment; unauthorized disclosure of member or employee sensitive or confidential information, including the impact and outcome of any investigations, inquiries, claims and litigation related thereto; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon; our ability to maintain and achieve improvement in Centers for Medicare and Medicaid Services, or CMS, Star ratings and other quality scores and funding risks with respect to revenue received from participation therein; a negative change in our healthcare product mix; costs and other liabilities associated with litigation, government investigations, audits or reviews; the ultimate outcome of litigation between Cigna Corporation and us related to the merger agreement between the parties and the potential for such litigation to cause us to incur substantial additional costs, including potential settlement and judgment costs; risks and uncertainties related to our pharmacy benefit management, or PBM, business including non-compliance by any party with the PBM services agreement between us and CaremarkPCS Health, L.L.C.; medical malpractice or professional liability claims or other risks related to healthcare and PBM services provided by our subsidiaries; general risks associated with mergers, acquisitions, joint ventures and strategic alliances; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; possible restrictions in the payment of dividends from our subsidiaries and increases in required minimum levels of capital; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; the potential negative effect from our substantial amount of outstanding indebtedness; a downgrade in our financial strength ratings; the effects of any negative publicity related to the health benefits industry in general or us in particular; failure to effectively maintain and modernize our information systems; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; the impact of international laws and regulations; changes in U.S. tax laws; intense competition to attract and retain employees; and various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations.

Investor Relations
Chris Rigg
Chris.Rigg@anthem.com

Media
Jill Becher, 414-234-1573
Jill.Becher@anthem.com

Source: Anthem, Inc.